Establishing a human-induced pluripotent stem cell line (SMUSHi003-A) from a patient with Charcot-Marie-Tooth disease and focal segmental glomerulosclerosis

Stem Cell Res. 2024 Apr:76:103357. doi: 10.1016/j.scr.2024.103357. Epub 2024 Feb 22.

Abstract

INF2 mutations cause Charcot-Marie-Tooth disease (CMT), and /or focal segmental glomerulosclerosis (FSGS) in an autosomal dominant inheritance mode, whose underlying mechanism remainsunclear. Here, we report the generation of an iPSC line from a female patient with CMT and FSGS. The iPSC line from the patient's PBMCscarried aheterozygous INF2 deletion mutation (c.315_323delGCGCGCCGT) within the conserved E2. This line exhibited a normal karyotype, high expression of pluripotency markers, and trilineage differentiation potential. This line can be used to dissect the complex pathomechanism through further induction of differentiation into related cells and as a drug screening tool for INF2-associated diseases.

MeSH terms

  • Charcot-Marie-Tooth Disease* / genetics
  • Female
  • Formins / genetics
  • Glomerulosclerosis, Focal Segmental* / genetics
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Microfilament Proteins / genetics
  • Microfilament Proteins / metabolism
  • Mutation

Substances

  • Microfilament Proteins
  • Formins